Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Clinical trial NCT01525407 · COMPLETED
Trial details
- NCT number
- NCT01525407
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2015-09-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.